Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Recursion Pharmaceuticals, Inc. Transaction History
Mitsubishi Ufj Kokusai Asset Management Co., Ltd.
- $107 Billion
- Q1 2025
A detailed history of Mitsubishi Ufj Kokusai Asset Management Co., Ltd. transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Mitsubishi Ufj Kokusai Asset Management Co., Ltd. holds 30,864 shares of RXRX stock, worth $155,245. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30,864
Previous 28,277
9.15%
Holding current value
$155,245
Previous $191,000
14.66%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding RXRX
# of Institutions
365Shares Held
286MCall Options Held
3.28MPut Options Held
3.16M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl34.8MShares$175 Million1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA32.3MShares$162 Million0.0% of portfolio
-
Baillie Gifford & CO24.4MShares$123 Million0.12% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$87.1 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M014.7MShares$73.8 Million0.27% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $908M
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...